| |
|
|
| |
W e l c o m e |
|
| |
| |
|
| |
Dr. Ranjan Duara, MD |
Welcome from Dr. Duara
These annual Symposia on Mild Cognitive Impairment (MCI) and early Alzheimer's Disease were initiated in 2003 to address the increasing interest in understanding the earliest stages of various disorders that may ultimately lead to dementia. Experts representing many different disciplines have contributed to the discussions at the MCI Symposia series and the feedback from the audience and the faculty in the last nine years has been very positive. We have every reason to believe that you will find the next meeting educational and intellectually stimulating. Please consider attending the Tenth Annual Symposium on January 14 and 15, 2012 in Miami Beach, Florida. If you would like more information about the symposium please feel free to contact us at mcisymposium@msmc.com
Educational Objectives
The purpose of this symposium and workshop is to provide a forum for new information and for in-depth discussions about advances in research, related to the clinical diagnosis and progression of Alzheimer's Disease (AD) and related disorders. This symposium and workshop will emphasize the early stage of AD and related disorders, and the preclinical deficits that are associated with increased risk for subsequent dementia. We will present results from several longitudinal and cross-sectional studies that have explored clinical, imaging and biomarker features that are related to AD. We will explore how these studies lay the groundwork for making an earlier and more accurate diagnosis of AD.
The symposium will include two keynote addresses and two individually themed symposia, each featuring national experts in the fields of neurology, psychiatry, geriatrics, neuropsychology, radiology, epidemiology and molecular biology. The workshop will feature two keynote addresses, and two mini-symposia with four case reports each. Each mini-symposium will be followed by an extended discussion period, allowing active audience participation to promote a better understanding of the issues.
Upon completion of this symposium and workshop, the attendees should be able to:
- Describe clinical features and biomarker results in atypical AD syndromes
- Name new concepts in the pathogenesis of AD
- Understand the utility of clinical and neuropsychological examination, CSF biomarkers and brain imaging in the early diagnosis of AD
- Explain how, when and to whom to disclose diagnostic results in people with normal cognition or mild cognitive impairment
Target Audience
This activity is designed for:
- Neurologists
- Psychiatrists
- Geriatricians / Gerontologists
- Epidemiologists
- Neuropsychologists
- Psychologists
- Neuroscientists
|
| |
|
|
